Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The Milwaukee, Wisconsin-based Sensient Technologies Corporation ( SXT - Snapshot Report ) reported fourth quarter 2011 earnings of 57 cents per share edging out the Zacks Consensus Estimate by a penny and surging 9.6% from the year-ago level of 52 cents. Reported earnings include a charge of 7 cents pertaining to a cost reduction plan and a gain of 7 cents per share related to the acquisition of Les Colorants Wackherr do Brasil. In fiscal 2011, earnings came in at $2.41 per share versus $2.17 in the prior year.
The better-than-expected results were attributable to higher operating income.
Total revenue inched up 0.3% year over year to $340.4 million during the quarter. Total revenue was impacted by 1% due to unfavorable currency exchange. In full-fiscal 2011, revenue increased 7.7% to $1.43 billion year over year.
Quarter Highlights
Sales of the Color Group segment dipped 0.4% year over year to $112.8 million during the quarter, due to unfavorable currency impact of 2%. Flavors & Fragrances Group reported revenue of $206.3 million, flat year over year, negatively impacted by 1% due to foreign currency translation. However, revenue at Corporate & Other, which includes the company’s operations in Asia Pacific and China, rose 4.6% to $30.8 million.
Notwithstanding the unfavorable currency impact of 1%, operating income of the Color Group segment leaped 10.6% to $20.3 million and that of Flavors & Fragrances Group spiked 9.3% to $29.4 million. Color Group segment operating income was driven by solid performance at North American operations and strong demand for natural colors while the same at Flavors & Fragrances Group benefited from U.S. flavor businesses.
Operating income of the company expanded 4.7% to $43.0 million due to cost saving initiatives introduced by the company in the quarter. Selling and administrative expenses climbed 6.6% to $65.2 million but cost of products sold decreased 2.1% to $232.2 million.
Financial Position
The company ended 2011 with cash flow from operations of $142.9 million, down 8.2% from the prior-year period. As of December 31, 2011, long-term debt was $312.4 million, down from $324.4 million as of December 31, 2010.
Outlook
The company expects 2012 earnings in the range of $2.48 to $2.58 per share.
Our Take
We remain optimistic on the stock given its better-than-expected results, continuous enhancement of shareholder value and strengthening balance sheet by debt reduction. The Zacks Consensus Estimates for the upcoming quarter and fiscal 2012 are 57 cents and $2.55 per share, respectively, reflecting year-over-year growth of 8.18% and 5.37%.
Sensient holds a Zacks #4 Rank, implying a short-term Sell rating. Besides, we are also maintaining our long-term Neutral recommendation on the stock.
One of Sensient Technologies’ primary competitors, McCormick & Co. Inc. ( MKC - Analyst Report ) posted results for the fourth quarter and fiscal year 2011 with operating earnings of $1.03 per share and $2.79 per share, respectively. The results surpassed the Zacks Consensus Estimate of 97 cents per share and $2.78 per share, respectively.
Read the full Snapshot Report on SXT
Read the full Analyst Report on MKC